2024-10-18  10:00:00 PM Chg. -0.3300 Volume Bid1:34:25 AM Ask1:34:25 AM Market Capitalization Dividend Y. P/E Ratio
41.1000USD -0.80% 307,211
Turnover: 8.54 mill.
40.7800Bid Size: 100 41.2700Ask Size: 100 1.89 bill.USD - -

Business description

Since 1992, Omnicell (NASDAQ: OMCL) has been creating innovative solutions to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software for medication and supply management across the entire health care continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.
 

Management board & Supervisory board

CEO
Randall Lipps
Management board
Nchacha Etta, Corey Manley, Minoo Mortazavi, Alex Pratt, Prasad Srinivasamurthy, Nish Parekh, Giri Chodavarapu, Vicki MacDevitt, Kathleen Nemeth, Max Rocha, Martha Thorne, David J. Vanella
Supervisory board
Randall Lipps, Joanne Bauer, Edward Bousa, Mary Garrett, Bobby Ghoshal, Mark Parrish, Rob Seim, Bruce E. Scott, Eileen Voynick, Sara J. White
 

Company data

Name: Omnicell Inc.
Address: 4220 North Freeway,Fort Worth, TX 76137
Phone: +1-877-415-9990
Fax: +1-877-602-4179
E-mail: -
Internet: www.omnicell.com/
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12-31
Free Float: 68.17%
IPO date: 2001-08-07

Investor relations

Name: Kathleen Nemeth
IR phone: -
IR Fax: -
IR e-mail: ir@omnicell.com

Main Shareholders

Freefloat
 
68.17%
BlackRock Inc. Inc.
 
15.47%
The Vanguard Group, Inc.
 
10.43%
Wellington Management Group LLP
 
5.93%